Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors

Bioorg Med Chem. 2019 Apr 15;27(8):1605-1618. doi: 10.1016/j.bmc.2019.03.005. Epub 2019 Mar 5.

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1) plays a vital role in tumor immune escape and has emerged as a promising target for cancer immunotherapy. In this study, a novel series of 2,5-dimethylfuran-3-carboxylic acid derivatives were designed, synthesized and evaluated for inhibitory activities against IDO1, and their structure-activity relationship was investigated. Among these, compound 19a exhibited excellent IDO1 inhibitory activity (HeLa cellular IC50 = 4.0 nM, THP-1 cellular IC50 = 4.6 nM). Further molecular docking studies revealed that the compound 19a formed a coordinate bond with the heme iron through the carboxylic acid moiety. These results indicate that compound 19a is a potential IDO1 inhibitor for further investigation.

Keywords: HeLa assay; IDO1 inhibitor; Immunotherapy; THP-1 assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Design*
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / metabolism
  • Furans / chemistry*
  • Furans / metabolism
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors*
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
  • Inhibitory Concentration 50
  • Molecular Docking Simulation
  • Protein Structure, Tertiary
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Furans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • 2,5-dimethylfuran